Arthex Biotech Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $298K
Latest Deal Amount
  • Investors
  • 4

Arthex Biotech General Information

Description

Developer of next generation of antisense ribonucleic acid (RNA) therapies intended to offer a treatment of myotonic dystrophy. The company's therapies are aimed to develop the first disease-modifying drug for myotonic dystrophy type I, the most common form of muscular dystrophy that begins in adulthood, which is currently universally disabling and lethal, enabling healthcare institutions to get access to therapy that helps treat patients suffering from genetic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Carrer del Catedràtic Agustín
  • Escardino Benlloch, 9
  • 46980 Valencia
  • Spain
+34 625 00 00 00

Arthex Biotech Timeline

20202021
Date FoundedFinancing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arthex Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 28-Nov-2020 $298K 00.000 Completed Generating Revenue
2. Seed Round 23-Jul-2020 00.000 00.000 Completed Generating Revenue
1. Accelerator/Incubator 02-Jun-2020 Completed Generating Revenue
To view Arthex Biotech’s complete valuation and funding history, request access »

Arthex Biotech Executive Team (2)

Name Title Board Seat Contact Info
Beatriz Llamusí Ph.D Co-Founder & Chief Executive Officer
Rubén Artero Ph.D Co-Founder & Advisor
To view Arthex Biotech’s complete executive team members history, request access »

Arthex Biotech Board Members (3)

Name Representing Role Since
Alain Huriez MD Self Board Member 000 0000
Albert Ferrer Invivo Capital Board Member 000 0000
Luís Pareras Ph.D Invivo Capital Board Member 000 0000
To view Arthex Biotech’s complete board members history, request access »

Arthex Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arthex Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advent France Biotechnology Venture Capital Minority 000 0000 000000 0
Centro para el Desarrollo Tecnológico Industrial Government Minority 000 0000 000000 0
Invivo Capital Venture Capital Minority 000 0000 000000 0
EIT Health Accelerator/Incubator 000 0000 000000 0
To view Arthex Biotech’s complete investors history, request access »